In a new move in the health IoT solutions business, Ericsson and partner Brighter, a Swedish health-tech company have introduced Actiste, billed as “the world’s first complete IoT-health solution for monitoring and treating insulin-dependent diabetes.”
Ericsson said in a press release that the introduction of the commercially-ready solution was announced at the recently-concluded GITEX in Dubai. With this, Brighter can deliver the Actiste Diabetes Management as a Service in the UAE and the wider Gulf Cooperation Council (GCC) with cross-border mobile connectivity to be provided by leading communication service providers.
Actiste has all the required functions for diabetes management on a single connected device: blood sampling, blood glucose measurement and insulin injection. The device is delivered as part of a subscription service, designed to simplify patient’s everyday life and optimise and improve treatments.
Henrik Norström, CEO, Brighter AB, said in the rpress note, “By partnering with Ericsson, we are able to offer a truly seamless customer experience. No matter where in the world patients decide to go, their generated health and treatment data will always be securely stored and available to improve their treatments.”
Fadi Pharaon, President of Ericsson Middle East and Africa, added, “Our global partnership with Brighter has now reached a stage of real deliveries to the market, utilising the global connectivity service based on our IoT Accelerator. The result is an enhanced healthcare industry in the UAE and wider GCC, and an improved quality of life for diabetes patients.”
The cellular-enabled, Actiste devices are managed by Ericsson’s IoT Accelerator and securely connected by leading communications service providers to deliver a consistent level of service and a single dashboard.
Image Credit: Ericcson